Local Institution

Viedma, Río Negro Province 8500

0 studies enrolling now · 3 studies all time

What they study most

Cancer of the Stomach, Gastric Cancer, Gastroesophageal Junction, Non-Small Cell Lung Cancer, Stomach Cancer, Urinary Bladder Neoplasms

Studies at this site

• A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder — Stopped early
• An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma — Withdrawn before enrolling
• A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer — Withdrawn before enrolling